JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 522
Type: Contributed
Date/Time: Wednesday, August 1, 2012 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract - #304890
Title: Power and Sample Size Estimation in Clinical Trials with Multiple Co-Primary Endpoints
Author(s): Zuoshun Zhang*+
Companies: Celgene Corporation
Address: 33 Technology Dr., Warren, NJ, 07059, United States
Keywords: co-primary endpoints ; power ; sample size ; correlation matrix ; positive definite matrix ; Cholesky decomposition

For some diseases, there needs to show the significance of a treatment in multiple co-primary endpoints. In the design stage, it will be helpful to have easily accessible tools for power and sample size estimation. Sozu et al. (J Biopharm Stat 2011, 650-668) provided formulas and gave examples for 2 and 3 co-primary endpoints using integration. For any number of co-primary endpoints, we give an alternative way for accurate and quick estimation for power and sample size. We factor the positive definite correlation matrix into a product using Cholesky decomposition and generate independent standard normal random numbers. The random numbers are transformed into correlated vectors corresponding to the sufficient test statistics of simulated trials, from which the power and sample size are estimated. For 2 or 3 continuous co-primary endpoints, we estimated the sample sizes and compared with t

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.